期刊文献+

抑癌基因PTEN与甲状腺肿瘤的相关研究进展 被引量:6

Advances in The Study of The Tumor Suppressor PTEN and Thyroid Tumor
原文传递
导出
摘要 目的归纳分析当前抑癌基因PTEN与甲状腺肿瘤的相关研究,深化对甲状腺肿瘤发生及发展机理的认识。方法通过检索国内外文献获取近年来与PTEN基因及甲状腺肿瘤相关的文献资料并进行综述。结果PTEN基因突变、启动子甲基化等导致PTEN蛋白表达异常,可导致其下游PI3K、m TOR、FAK等多种信号分子异常激活,进而促进甲状腺良恶性肿瘤的发生及性质演进。结论 PTEN基因及其下游信号通路异常与甲状腺肿瘤的形成及病理性质恶化之间存在相关性,但目前具体机理仍未完全明确,仍有待进一步研究。 Objective To summarize and analyze the relevant studies about the tumor suppressor phosphatase and tensin homolog deleted on chromosome ten(PTEN) and thyroid tumor then further elucidate the possible mechanism of thyroid tumor formation and progression. Mothods Domestic and international literatures investigating the correlation between PTEN and thyroid tumor were retrieved and reviewed. Results The abnormal expression of PTEN protein resulted by the mutation or methylation of PTEN gene may up-regulate the expression of its downstream effectors such as PI3 K, m TOR, FAK, etc. This probably correlate with thyroid neoplasia and progression. Conclusions Abnormalites of PTEN and its downstream signal ways may correlate with the initiation and development of thyroid tumors. However, the specific mechanism still remains unclear and need more further researches.
出处 《中国普外基础与临床杂志》 CAS 2016年第4期503-506,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 四川省科技厅项目(项目编号:2014SZ0192)~~
关键词 PTEN 抑癌基因 抑癌作用机理 PTEN错构瘤综合征 甲状腺肿瘤 PTEN Tumor suppressor gene Anti-tumor mechanism PTEN-hamartoma syndrome Thyroid tumor
  • 相关文献

参考文献43

  • 1Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transfor- ming growth factor beta. Cancer Res, 1997, 57(11): 2124-2129.
  • 2Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candi- date tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet, 1997, 15(4): 356-362.
  • 3Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phos- phatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5308): 1943-1947.
  • 4Sansal I, Sellers WR. the biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol, 2004, 22(14): 2954-2963.
  • 5Davies L, Welch HG.Current thyroid cancer trends in the United States. lAMA Otolaryngol Head Neck Surg, 2014, 140(4): 317-322.
  • 6Worby CA, Dixon JE. PTEN. Annu Rev Biochem, 2014, 83: 641-669.
  • 7Baquero P, Jimnez-Mora E, Santos A, et al. TGFbeta induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways. Mol Carcinog, 2015 Sep 21. [Epub ahead of printJ.
  • 8Tai YL, Chen LC, Shen TL. Emerging roles of focal adhesion ldnase in cancer. Biomed Res Int, 2015, 2015: 690690.
  • 9Chetram MA, Don-Salu-Hewage AS, Hinton CV. ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. Biochem Biophys Res Commun, 2011,410(2): 195-200.
  • 10Tamura M, Gu J, Danen EH, et aL PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix- dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem, 1999, 274(29): 20693-20703.

同被引文献72

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部